Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Serretta

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|January 1, 1986
[Use of flutamide in the treatment of carcinoma of the prostate stages C and D (T3-T4, Nx-N0, M0-M1 categories)]G Daricello, G Caramia, F P Rizzo, et al.
European Urology|January 1, 1988
Chronic prostatitis and prostatodynia: ultrasonographic alterations of the prostate, bladder neck, seminal vesicles and periprostatic venous plexusD Di Trapani, C Pavone, V Serretta, et al.
Urological Research|January 1, 1993
Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot studyV Serretta, G Corselli, B Piazza, et al.
Urologia|November 25, 2010
[Low-risk bladder tumors: How accurate are the EORTC Risk Tables?]D Passalacqua, V Serretta, A Ruggirello, et al.
Progress in Clinical and Biological Research|January 1, 1988
Transurethral ultrasonography, CT scan, nuclear magnetic resonance (NMR) imaging and pathological control in staging and follow up of invasive bladder carcinomaC Pavone, D Di Trapani, V Serretta, et al.
Progress in Clinical and Biological Research|January 1, 1990
Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?M Pavone-Macaluso, V Serretta, G Daricello, et al.
Prostate Cancer and Prostatic Diseases|July 20, 2007
PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patientsV Serretta, A Catanese, G Daricello, et al.
Urologia|November 25, 2010
[Conservative management and survival of patients affected by T1G3 bladder tumours. When shall we indicate it and when the cystectomy?]A Ruggirello, V Serretta, D Passalacqua, et al.
European Urology|April 15, 2000
Correlation between chronic prostatitis syndrome and pelvic venous disease: a survey of 2,554 urologic outpatientsC Pavone, E Caldarera, P Liberti, et al.
European Urology|January 1, 1992
Intravesical therapy of superficial bladder transitional cell carcinoma with tumor necrosis factor-alpha: preliminary report of a phase I-II studyV Serretta, G Corselli, B Piazza, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|January 1, 1986
[Use of flutamide in the treatment of carcinoma of the prostate stages C and D (T3-T4, Nx-N0, M0-M1 categories)]G Daricello, G Caramia, F P Rizzo, et al.
European Urology|January 1, 1988
Chronic prostatitis and prostatodynia: ultrasonographic alterations of the prostate, bladder neck, seminal vesicles and periprostatic venous plexusD Di Trapani, C Pavone, V Serretta, et al.
Urological Research|January 1, 1993
Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-alpha-2b combined with epirubicin: a pilot studyV Serretta, G Corselli, B Piazza, et al.
Urologia|November 25, 2010
[Low-risk bladder tumors: How accurate are the EORTC Risk Tables?]D Passalacqua, V Serretta, A Ruggirello, et al.
Progress in Clinical and Biological Research|January 1, 1988
Transurethral ultrasonography, CT scan, nuclear magnetic resonance (NMR) imaging and pathological control in staging and follow up of invasive bladder carcinomaC Pavone, D Di Trapani, V Serretta, et al.
Progress in Clinical and Biological Research|January 1, 1990
Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?M Pavone-Macaluso, V Serretta, G Daricello, et al.
Prostate Cancer and Prostatic Diseases|July 20, 2007
PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patientsV Serretta, A Catanese, G Daricello, et al.
Urologia|November 25, 2010
[Conservative management and survival of patients affected by T1G3 bladder tumours. When shall we indicate it and when the cystectomy?]A Ruggirello, V Serretta, D Passalacqua, et al.
European Urology|April 15, 2000
Correlation between chronic prostatitis syndrome and pelvic venous disease: a survey of 2,554 urologic outpatientsC Pavone, E Caldarera, P Liberti, et al.
European Urology|January 1, 1992
Intravesical therapy of superficial bladder transitional cell carcinoma with tumor necrosis factor-alpha: preliminary report of a phase I-II studyV Serretta, G Corselli, B Piazza, et al.
Pageof 6